Login / Signup

Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE-AF registry.

Johanna P ContrerasKimberly N HongJavier CastilloLucas N MarzecJonathan C HsuChristopher P CannonSong YangThomas M Maddox
Published in: Clinical cardiology (2019)
Patients with NVAF and HFpEF have significantly lower anticoagulation rates when compared to their HFrEF counterparts. These findings suggest a potential underappreciation of HFpEF as a risk factor in patients with NVAF.
Keyphrases
  • atrial fibrillation
  • heart failure
  • risk factors
  • venous thromboembolism
  • left ventricular
  • cardiac resynchronization therapy
  • human health